Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combinatorial Gene Control

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Internal Receptors

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.

Small interfering RNAs (siRNA)

Small interfering RNAs (siRNA)

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Poly(I:C) Lipoamino Bundle LNPs Induce Tumor Cytotoxicity and Immune Activation with Enhanced Efficacy by Survivin Silencing.

International journal of molecular sciences·2026

Same author

mRNA Delivery by Lipoamino Fatty Acid-Peptide Polyplexes in Different Lung Cell Models and Lungs.

Polymers·2026

Same author

Spatiotemporal Nanotransformers for Antitumoral Orchestration of Protein Homeostasis.

Polymer science & technology (Washington, D.C.)·2026

Same author

Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head Groups.

Bioconjugate chemistry·2026

Same author

Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70.

MedComm·2026

Same author

Hydrophobic Refinement of Polarity-Switchable Lipo-Xenopeptides Modulates Endosomal Escape and Enhances mRNA Delivery In Vitro and In Vivo.

Journal of the American Chemical Society·2026

Search research articles

Related Experiment Video

Updated: Jan 24, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Combinatorial siRNA Polyplexes for Receptor Targeting.

Dian-Jang Lee^1,2, Ernst Wagner^3,4

¹Department of Pharmacy, Center for NanoScience, Ludwig-Maximilians-Universität München, Munich, Germany.

Methods in Molecular Biology (Clifton, N.J.)

|May 18, 2019

Summary

This summary is machine-generated.

Researchers developed targeted, folate-conjugated siRNA polyplexes for cancer therapy. These delivery systems efficiently silenced genes in tumors expressing folate receptors, showing promise for targeted cancer treatment.

Keywords:

Gene silencing Polyplex Receptor targeting siRNA delivery

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart

Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart

Published on: July 29, 2018

Related Experiment Videos

Last Updated: Jan 24, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart

Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart

Published on: July 29, 2018

Area of Science:

Biotechnology
Nanomedicine
Cancer Research

Background:

Small interfering RNA (siRNA) holds therapeutic potential for cancer by targeting specific genes.
Developing effective and tumor-specific siRNA delivery systems remains a significant challenge in cancer therapy.
Folate receptors are overexpressed in various cancer cells, making them attractive targets for drug delivery.

Purpose of the Study:

To design and synthesize novel folate-conjugated combinatorial siRNA polyplexes for targeted cancer therapy.
To evaluate the efficiency of these polyplexes in delivering siRNA to folate receptor-expressing tumors.
To assess the gene silencing capabilities and tumor-killing effects of the developed delivery system.

Main Methods:

Solid-phase-supported synthesis of sequence-defined oligomer platform for polyplex formation.
Conjugation of folate to the oligomer platform to create targeted carriers.
In vitro and in vivo evaluation of polyplex formation, siRNA delivery, and gene silencing efficacy.
Assessment of receptor-directed cancer cell killing.

Main Results:

Successful generation of folate-conjugated targeted combinatorial siRNA polyplexes.
Demonstrated efficient siRNA delivery and gene silencing in folate receptor-expressing tumors.
Observed effective receptor-directed cell killing in cancer cells in vitro and in vivo.

Conclusions:

Folate-conjugated siRNA polyplexes represent a promising strategy for targeted cancer therapy.
The developed delivery system enables efficient cytosolic and systemic delivery of siRNA to tumors.
This approach offers a potential platform for developing novel cancer treatments with enhanced specificity.